Results 101 to 110 of about 3,115 (154)

Error in Figure.

JAMA Neurol
europepmc   +1 more source

Adjunctive Intravenous Argatroban or Eptifibatide for Ischemic Stroke. [PDF]

N Engl J Med
Adeoye O, Broderick J, Derdeyn CP, Grotta JC, Barsan W, Bentho O, Berry S, Concha M, Davis I, Demel S, Elm J, Gentile N, Graves T, Hoffman M, Huang J, Ingles J, Janis S, Jasne AS, Khatri P, Levine SR, Majjhoo A, Panagos P, Pancioli A, Pizzella S, Ranasinghe T, Sabagha N, Sivakumar S, Streib C, Vagal A, Wilson A, Wintermark M, Yoo AJ, Barreto AD.   +32 more
europepmc   +1 more source

Implications of GPIIB-IIIA Integrin and Liver X Receptor in Platelet-Induced Compression of Ovarian Cancer Multi-Cellular Spheroids. [PDF]

Cancers (Basel)
Isingizwe ZR, Sjoelund V, Benbrook DM.
europepmc   +1 more source

Mass balance and metabolite profiling of ¹⁴C-Zalunfiban in humans following single-dose subcutaneous administration. [PDF]

Xenobiotica
MacArthur RB, Rikken SAOF, Vootukuri SR, Coller BS, Gibson CM, Granger CB, Montalescot G, Berg JMT, Ducharme MP, van 't Hof AWJ.   +9 more
europepmc   +1 more source

The Budget Impact of Cangrelor in the UK for the Treatment of Out-of-Hospital Cardiac Arrest Patients Who Require Percutaneous Coronary Intervention. [PDF]

Clinicoecon Outcomes Res
Modi B, Cain R, Stork R, Barwood C, Tarpey G, Colucciello A.   +5 more
europepmc   +1 more source

Secondary risks of bleeding and associated outcome after tirofiban application during interventional treatment of intracranial aneurysms. [PDF]

Brain Spine
Griessmair M, Bodden J, Hedderich DM, Kirschke J, Maegerlein C, Renz M, Platzek P, Meyer B, Zimmer C, Wostrack M, Boeckh-Behrens T, Schwarting J.   +11 more
europepmc   +1 more source